On the controversy over the Ildong Pharmaceutical’s management against Green Cross, Ildong was able to smile

Published: 2015-03-24 14:21:11

Updated: 2015-03-24 14:21:11

Ildong Pharmaceutical has successfully defended the management.

The proposal to appoint internal director (CEO and president Jung-chi Lee of Ildong Pharmaceutical) and outside director (president Chang-rok Seo of Human Asia) recommended by Ildong Pharmaceutical has passed at its shareholders’ general meeting held on the 20^th.

Green Cross, which made the shareholder proposal, has practically w...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.